Greenlight Biosciences
GreenLight Biosciences is on a mission to save the world’s food system by eliminating the need for chemical-based pesticides.
RNA innovations
Greenlight’s revolutionary RNA innovations enable the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control with many applications across life and plant sciences.
“The big problems we’re thinking about at GreenLight are complex and don’t have a quick fix or silver bullet solution. Solving them requires new approaches that work with nature, not against it.”
- Andrey Zarur, Ph. D, Co-founder, President, and CEO
GreenLight Biosciences is a pioneering biotech company harnessing RNA-based solutions to transform agriculture and environmental health. With its groundbreaking cell-free RNA production platform, GreenLight delivers scalable, high-quality, affordable RNA for sustainable crop protection—such as its EPA-approved Calantha™ spray that combats Colorado potato beetles without harming beneficial insects, and its Norroa program targeting Varroa mite infestations to support honey bee health. The company’s diverse pipeline also includes RNA fungicides, herbicides, and adjuvants, all designed to degrade rapidly in the environment and leave no residue, reinforcing its commitment to both food security and ecological stewardship. A mission-driven Public Benefit Corporation founded in 2008 and based in Medford, MA, GreenLight’s innovations underscore its leadership in delivering nature-inspired, precision biotechnologies that empower growers, protect pollinators, and foster a more sustainable future for global agriculture.
In the News
Breakthrough in RNA Herbicide Development
GreenLight Biosciences has announced a major breakthrough in RNA-based herbicide development, demonstrating effective, sustainable weed control that reduces environmental impact and chemical use while addressing herbicide resistance.
GreenLight Biosciences Announces Close of Additional Financing
GreenLight Biosciences has closed a Series C funding round with a $25 million investment from Just Climate to support global expansion and commercialization of its RNA-based crop protection technologies, advancing sustainable agriculture and biodiversity conservation.
GreenLight Biosciences Arrives in Brazil
GreenLight Biosciences has received EPA approval for Calantha™, the first RNA-based bioinsecticide to target the Colorado potato beetle, marking a major milestone in sustainable agriculture with a highly specific, eco-friendly solution that reduces chemical pesticide use and protects biodiversity.
GreenLight Biosciences Announces EPA Registration of Calantha
GreenLight Biosciences Secures EPA Registration for new bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System